Plasma from Young Rats Reduces Epigenetic Age Measures and Senescent Cell Burden in Old Rats

This study is interesting on a few counts. Firstly, transfusion of old individuals with plasma from young individuals has failed to produce usefully large benefits in human trials, and the evidence in mice looks similarly shaky. Yet here, in rats, benefits are observed with a specific approach to producing a plasma fraction for use in therapy. The authors do not divulge details regarding the methodology of production, as they intend commercial development in the near future. Secondly, it connects epigenetic age reduction with reduction in senescent cell burden. It is worth noting that the epigenetic clocks used here to assess biological age are new, not existing clocks, however. The reduction in senescent cells is thus the more interesting measure to result from the study. As a final note, only a small number of rats were used in the plasma transfusion portion of the study, so this is very much a result that requires replication.

Young blood plasma is known to confer beneficial effects on various organs in mice. However, it was not known whether young plasma rejuvenates cells and tissues at the epigenetic level; whether it alters the epigenetic clock, which is a highly-accurate molecular biomarker of aging. To address this question, we developed and validated six different epigenetic clocks for rat tissues that are based on DNA methylation values derived from n=593 tissue samples. As indicated by their respective names, the rat pan-tissue clock can be applied to DNA methylation profiles from all rat tissues, while the rat brain-, liver-, and blood clocks apply to the corresponding tissue types. We also developed two epigenetic clocks that apply to both human and rat tissues by adding n=850 human tissue samples to the training data.

We employed these six clocks to investigate the rejuvenation effects of a plasma fraction treatment in different rat tissues. The treatment more than halved the epigenetic ages of blood, heart, and liver tissue. A less pronounced, but statistically significant, rejuvenation effect could be observed in the hypothalamus. The treatment was accompanied by progressive improvement in the function of these organs as ascertained through numerous biochemical/physiological biomarkers and behavioral responses to assess cognitive functions. Cellular senescence, which is not associated with epigenetic aging, was also considerably reduced in vital organs. Overall, this study demonstrates that a plasma-derived treatment markedly reverses aging according to epigenetic clocks and benchmark biomarkers of aging.



This is, of course, a really big deal if it can be replicated. That Steve Horvath is involved makes me confident that this could be a game-changer. Dr. Sinclair has talked to the authors and he believes it's legit so the next year is going to be very interesting.

Posted by: Larry at May 12th, 2020 9:46 AM

Wouldn't it be expected to have less senescent cells with a rejuvenated immune system to remove them?

Posted by: Lee at May 13th, 2020 6:09 AM

Not necessarily. Transplanted senecent cells don't all get killed in young mice but even turn their neighbors into ScC

Posted by: Cuberat at May 13th, 2020 8:17 AM

You may be right but here is a reply from the author:

"But whether this applies to the abilities of immune cells we don't have experimental evidence for, however the disappearance of senescent cells (assayed by the rude and imprecise presence of SA-beta galactosidase staining - not enough to definitively implicate senescent cells (p16Ink4a expression in combination would be enough) but what else would explain the effects of Elixir and the disappearance of Senescence-Asssociated beta galactosidase staining cells after Elixir treatment?"

Posted by: Lee at May 13th, 2020 3:38 PM

Well, haven' t we been there before?
Exceptionally long lived, healthy, youthful rats...
Buckminster Fullerenes/ anyone? 2012? Oh, the hype that followed...

The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene.

What has come of that? With the exception of some vendors of C60-olive oil solutions got rich(er) from anti-aging enthusiasts... nothing.

I wouldn't hold my breath that the latest 'breakthrough' has a bigger effect size on humans than bleached age-spots...

I sure hope I'm wrong and this time will be different and history does not repeat.

Posted by: Jones at May 15th, 2020 10:21 PM

How can it ever be replicated if the authors used a " ...specific approach to producing a plasma fraction for use in therapy. The authors do not divulge details regarding the methodology of production..." ?

Posted by: Vic at May 22nd, 2020 1:36 PM
Comment Submission

Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.